[1] Al-Hashimi I, Schifter M, Lockhart PB, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 103 Suppl∶S25.e1-12 [2] Thongprasom K, Prapinjumrune C, Carrozzo M. Novel therapies for oral lichen planus [J]. J Oral Pathol Med, 2013, 42(10)∶721-727 [3] Smolen JS. Treat-to-target: rationale and strategies [J]. Clin Exp Rheumatol, 2012, 30(4 Suppl 73)∶S2-6 [4] Bouguen G, Levesque BG, Feagan BG, et al. Treat to target: a proposed new paradigm for the management of Crohn's disease [J]. Clin Gastroenterol Hepatol, 2015, 13(6)∶1042-1050 [5] Mosca M, Boumpas DT, Bruce IN, et al. Treat-to-target in systemic lupus erythematosus: where are we today [J]? Clin Exp Rheumatol, 2012, 30(4 Suppl 73)∶S112-115 [6] 杨岫岩,邱茜.应关注系统性红斑狼疮目标治疗的新理念[J].中华医学杂志,2014,94(37)∶2881-2883 [7] Sitbon O, Baloira Villar A, Bauer F, et al. Treat-to-target approach in pulmonary arterial hypertension: a consensus-based proposal [J]. Eur Respir Rev, 2012, 21(125)∶259-262 [8] Garber AJ. Treat-to-target trials: uses, interpretation and review of concepts [J]. Diabetes Obes Metab, 2014, 16(3)∶193-205 [9] Stoffer MA, Schoels MM, Smolen JS, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update [J]. Ann Rheum Dis, 2016, 75(1)∶16-22 [10] Roberts AL, Rizzolo D. Systemic lupus erythematosus: an update on treat-to-target [J]. JAAPA, 2015, 28(9)∶22-28 [11] Gulliver W, Lynde C, Dutz JP, et al. Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque Psoriasis [J]. J Cutan Med Surg, 2015, 19(1)∶22-27 [12] Smolen JS, Breedveld FC, Burmester GR, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force [J]. Ann Rheum Dis, 2016, 75(1)∶3-15 [13] van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force [J]. Ann Rheum Dis, 2014, 73(6)∶958-967 [14] 栗占国.应强调风湿免疫病治疗中完全缓解的理念[J].中华医学杂志,2011,91(11)∶721-722 [15] Lodi G, Scully C, Carrozzo M, et al. Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2005, 100(2)∶164-178 [16] 中华口腔医学会口腔黏膜病专业委员会,中华口腔医学会中西医结合专业委员会.口腔扁平苔藓诊疗指南(试行)[J].中华口腔医学杂志,2012,47(7)∶399-401 [17] Wang J, van der Waal I. Disease scoring systems for oral lichen planus; a critical appraisal [J]. Med Oral Patol Oral Cir Bucal,2015,20(2)∶e199-204 [18] Piboonniyom SO, Treister N, Pitiphat W, et al. Scoring system for monitoring oral lichenoid lesions: a preliminary study [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2005, 99(6)∶696-703 [19] Escudier M, Ahmed N, Shirlaw P, et al. A scoring system for mucosal disease severity with special reference to oral lichen planus [J]. Br J Dermatol, 2007, 157(4)∶765-770 [20] 中华口腔医学会口腔黏膜病专业委员会.口腔扁平苔藓(萎缩型、糜烂型)疗效评价标准(试行)[J].中华口腔医学杂志,2005,40(2)∶92-93 [21] Pincus T, Castrejón I. Evidence that the strategy is more important than the agent to treat rheumatoid arthritis. Data from clinical trials of combinations of non-biologic DMARDs, with protocol-driven intensification of therapy for tight control or treat-to-target [J]. Bull Hosp Jt Dis (2013), 2013,71(1)∶S33-40 |